Similar results were obtained when we tested the combined effect of MDK/ALK axis inhibitors and cannabinoids, a novel family of potential anticancer agents 39, 40 that have been shown to synergize with ALK inhibitors in differentiated glioma cells 13, 39, 40. The gene discussed is ALK; the disease is glioma.